[1] Glaziou P, Floyd K, Raviglione MC. Global epidemiology of tuberculosis[J]. Semin Respir Crit Care Med, 2018, 39(3): 271-285. DOI: 10.1055/s-0038-1651492.
[2] Abulfathi AA, Decloedt EH, Svensson EM, et al. Clinical pharmacokinetics and pharmacodynamics of rifampicin in human tuberculosis[J]. Clin Pharmacokinet, 2019, 58(9): 1103-1129. DOI: 10.1007/s40262-019-00764-2.
[3] Nikonenko BV, Bocharova IV, Lepekha LN. Drug resistance of mouse somatic cells to rifampicin in experimental tuberculosis[J]. Bull Exp Biol Med, 2021, 171(1):53-55. DOI: 10.1007/s10517-021-05171-x.
[4] 吴龙章,钟炳棠,刘燕文,等. 对«结核病诊断细菌学检验规程»的一点看法[J]. 中国防痨杂志,2012,34(3):192-193.
[5] Ning Q, Wang D, Cheng F, et al. Predicting rifampicin resistance mutations in bacterial RNA polymerase subunit beta based on majority consensus[J]. BMC Bioinformatics, 2021, 22(1): 210. DOI: 10.1186/s12859-021-04137-0.
[6] Do TT, Rodríguez-Beltran J, Cebrián-Sastre E, et al. Inactivation of a new potassium channel increases rifampicin resistance and induces collateral sensitivity to hydrophilic antibiotics in mycobacterium smegmatis[J]. Antibiotics (Basel), 2022, 11(4):509. DOI: 10.3390/antibiotics11040509.
[7] Yang J, Zheng X, Zhang S, et al. Epidemiology-based analysis of characteristics of dual infection of tuberculosis /acquired immune deficiency syndrome (AIDS) and drug resistance mechanism of related genes[J]. Cell Mol Biol (Noisy-le-grand), 2022, 68(2): 109-118. DOI: 10.14715/cmb/2022.68.2.16.
[8] Alemu A, Tadesse M, Seid G, et al. Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? review of cases from Addis Ababa, Ethiopia[J]. BMC Infect Dis, 2020, 20(1):87. DOI: 10.1186/s12879-020-4817-2.
[9] Kouemo Motse FD, Nsagha DS, Teyim PM, et al. Rifampicin resistance among mycobacterium tuberculosis-infected individuals using GeneXpert MTB/RIF ultra: a hospital-based study[J]. Trop Med Int Health, 2021, 26(2): 159-165. DOI: 10.1111/tmi.13489.
[10] Rando-Segura A, Aznar ML, Moreno MM, et al. Molecular characterization of rpoB gene mutations in isolates from tuberculosis patients in Cubal, Republic of Angola[J]. BMC Infect Dis, 2021, 21(1):1056. DOI: 10.1186/s12879-021-06763-8.
[11] Adhikari S, Saud B, Sunar S, et al. Status of rpoB gene mutation associated with rifampicin-resistant mycobacterium tuberculosis isolated in a rural setting in Nepal[J]. Access Microbiol, 2021, 3(3): 000202. DOI: 10.1099/acmi.0.000202.
[12] Alamgir M, Sajjad M, Baig MS, et al. Mutational frequencies in mycobacterial rpoB gene using GeneXpert/MTB Rif assay in rifampicin resistant patients at a tertiary care setting in Urban Sindh, Pakistan: analysis from a five-year period[J]. Pak J Med Sci, 2021, 37(4): 1151-1154. DOI: 10.12669/pjms.37.4.3875.
[13] Kay AW, Ness T, Verkuijl SE, et al. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children[J]. Cochrane Database Syst Rev, 2022, 9(9): CD013359. DOI: 10.1002/14651858.CD013359.pub3.
[14] Bobba S, Khader SA. Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye[J]. Trends Immunol, 2023, 44(9): 712-723. DOI: 10.1016/j.it.2023.07.003.
[15] Franco-Sotomayor G, Garzon-Chavez D, Leon-Benitez M, et al. A first insight into the katG and rpoB gene mutations of multidrug-resistant mycobacterium tuberculosis strains from Ecuador[J]. Microb Drug Resist, 2019, 25(4):524-527. DOI: 10.1089/mdr.2018.0203.
[16] Leehan JD, Nicholson WL. The spectrum of spontaneous rifampin resistance mutations in the bacillus subtilis rpoB gene depends on the growth environment[J]. Appl Environ Microbiol, 2021, 87(22): e0123721. DOI: 10.1128/AEM.01237-21.
[17] 王瑞武,李敏岚,韩嘉旭,等. 适合度的相对性与路径依赖的自然选择[J]. 生物多样性,2022,30(1):144-155. DOI:10.17520/biods.2021323.
[18] Polu GP, Mohammad Shaik J, Kota NMK, et al. Analysis of drug resistance mutations in pulmonary mycobacterium tuberculosis isolates in the Southern coastal region of Andhra Pradesh, India[J]. Braz J Infect Dis, 2019, 23(5): 281-290. DOI: 10.1016/j.bjid.2019.07.002.
[19] 陈蕾. 四川地区结核分枝杆菌katG、inhA和rpoB基因突变位点耐药水平及突变频率特征分析[J]. 临床肺科杂志,2022,27(2):242-246. DOI:10.3969/j.issn.1009-6663. 2022.02.017.
[20] 胡族琼,刘燕文,周文,等. 结核分枝杆菌rpoB基因突变特征与利福平耐药水平关系的研究[J]. 中国人兽共患病学报,2016,32(1):39-44,50. DOI:10.3969/j.issn.1002-2694. 2016.01.009.
|